$0.732
-0.0947 (-11.46%)
At Close: Jun 03, 2026
AIM ImmunoTech Added to Russell Microcap(R) Index
10:55am, Monday, 29'th Jun 2020
OCALA, FL / ACCESSWIRE / June 29, 2020 / AIM ImmunoTech (NYSE American:AIM), today announced that it has been added to the Russell Microcap® Index, following the annual Russell indexes reconstitution
Hemispherx BioPharma (NYSEAMERICAN:HEB) Share Price Crosses Above 200 Day Moving Average of $0.00
01:52am, Friday, 26'th Jun 2020
Hemispherx BioPharma, Inc (NYSEAMERICAN:HEB) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.00 and traded as high as
Receives clearance from Argentina's FDA to import first shipment of Ampligen® for commercial sale in Argentina AIM 'sets sights' on treating COVID-19 induced chronic fatigue in Argentin
AIM ImmunoTech Provides Update on Commercial Launch of Ampligen(R) in Argentina for the Treatment of Chronic Fatigue Syndrome
12:00pm, Monday, 15'th Jun 2020
OCALA, FL / ACCESSWIRE / June 15, 2020 / AIM ImmunoTech (NYSE American:AIM), today provided an update on the commercial launch of Ampligen® for the treatment of severe Chronic Fatigue Syndrome (CFS)
OCALA, FL / ACCESSWIRE / June 11, 2020 / AIM ImmunoTech (NYSE American:AIM), today announced that it has filed a provisional patent application for, among other discoveries, the use of its experimenta
The
Skegness holiday parks could stay open longer after devastating virus impact
12:49pm, Sunday, 24'th May 2020
It's estimated that 90 percent of staff in the sector have been furloughed
Holiday park plan revealed after shock impact of virus on coast emerges
03:49pm, Tuesday, 19'th May 2020
The season looks set to be scrapped
Call for planned new cinema to move for velodrome and cycling museum
03:11pm, Monday, 18'th May 2020
Cycling campaigners want to change the layout of the Firepool development site in Taunton
OCALA, FL / ACCESSWIRE / May 14, 2020 / AIM ImmunoTech (NYSE American:AIM) today announced that the U.S. Food and Drug Administration has authorized the first human trial assessing the safety and effe
What does COVID-19 do to the body?
10:47pm, Thursday, 07'th May 2020
"Three weeks in hell" or a bad cold? What does COVID-19 feel like, and how does your body fight back?
Stocks To Watch: Jobs Report, Virtual Conferences And Blue Chips On Tap
01:09pm, Saturday, 02'nd May 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
AIM ImmunoTech’s CEO to Present at Maxim’s Infectious Disease Virtual Conference
10:30am, Wednesday, 29'th Apr 2020
OCALA, FL / ACCESSWIRE / April 29, 2020 / AIM ImmunoTech Inc. (NYSE American:AIM), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral dis
BBBY, DVAX among premarket gainers
01:22pm, Tuesday, 28'th Apr 2020
Broadwind Energy (NASDAQ:BWEN) +60%. on $19M order.TrovaGene (NASDAQ:TROV) +44% on new positive results from its ongoing Phase 1b/2 clinical trial of onvansertib in combination with FOLFIRI and Avast
Facebook Takes Aim At Zoom With Video Chat Upgrade
09:10pm, Friday, 24'th Apr 2020
Facebook takes aim at Zoom with video chat upgrade
Sign In
Buy AIM